Molecular testing service refers to a type of diagnostic testing that analyzes genetic material, such as DNA or RNA, to detect specific genetic variations, mutations, or markers associated with certain diseases, conditions, or traits. This type of testing is often used in medical and research settings to identify and diagnose genetic disorders, determine the risk of developing certain diseases, guide treatment decisions, and assess the effectiveness of therapies. Molecular testing services may be offered by specialized laboratories or healthcare providers and can include various techniques such as polymerase chain reaction (PCR), DNA sequencing, and gene expression analysis.
The global Molecular Testing Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Molecular Testing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Molecular Testing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Molecular Testing Service in Biotechnology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Molecular Testing Service include Merck, Roche, ACM Global Laboratories, Molecular Testing Labs, Lab Test One, Hong Kong Molecular Pathology Diagnostic Centre (HKMPDC), Promega, Quest Diagnostics Test Directory and The Doctors Laboratory, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Molecular Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Testing Service.
Report Scope
The Molecular Testing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Roche
ACM Global Laboratories
Molecular Testing Labs
Lab Test One
Hong Kong Molecular Pathology Diagnostic Centre (HKMPDC)
Promega
Quest Diagnostics Test Directory
The Doctors Laboratory
Mayo Clinic Laboratories
Athena Diagnostics
Rosalind Franklin University
Centre for Health Protection
Queen Mary Hospital
Pharmigene
Dr Lal PathLabs
Molecular Diagnostic Services
National Jewish Health
UCLA Health
Cytiva
Segment by Type
Drug Testing
Virus Detection
Other
Segment by Application
Biotechnology
Medical
Laboratory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Testing Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Testing Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drug Testing
1.2.3 Virus Detection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Molecular Testing Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 Laboratory
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Testing Service Market Perspective (2019-2030)
2.2 Molecular Testing Service Growth Trends by Region
2.2.1 Global Molecular Testing Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Molecular Testing Service Historic Market Size by Region (2019-2024)
2.2.3 Molecular Testing Service Forecasted Market Size by Region (2025-2030)
2.3 Molecular Testing Service Market Dynamics
2.3.1 Molecular Testing Service Industry Trends
2.3.2 Molecular Testing Service Market Drivers
2.3.3 Molecular Testing Service Market Challenges
2.3.4 Molecular Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Testing Service Players by Revenue
3.1.1 Global Top Molecular Testing Service Players by Revenue (2019-2024)
3.1.2 Global Molecular Testing Service Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Testing Service Revenue
3.4 Global Molecular Testing Service Market Concentration Ratio
3.4.1 Global Molecular Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Testing Service Revenue in 2023
3.5 Molecular Testing Service Key Players Head office and Area Served
3.6 Key Players Molecular Testing Service Product Solution and Service
3.7 Date of Enter into Molecular Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Testing Service Breakdown Data by Type
4.1 Global Molecular Testing Service Historic Market Size by Type (2019-2024)
4.2 Global Molecular Testing Service Forecasted Market Size by Type (2025-2030)
5 Molecular Testing Service Breakdown Data by Application
5.1 Global Molecular Testing Service Historic Market Size by Application (2019-2024)
5.2 Global Molecular Testing Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Molecular Testing Service Market Size (2019-2030)
6.2 North America Molecular Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Molecular Testing Service Market Size by Country (2019-2024)
6.4 North America Molecular Testing Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Testing Service Market Size (2019-2030)
7.2 Europe Molecular Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Molecular Testing Service Market Size by Country (2019-2024)
7.4 Europe Molecular Testing Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Testing Service Market Size (2019-2030)
8.2 Asia-Pacific Molecular Testing Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Molecular Testing Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Molecular Testing Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Testing Service Market Size (2019-2030)
9.2 Latin America Molecular Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Molecular Testing Service Market Size by Country (2019-2024)
9.4 Latin America Molecular Testing Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Testing Service Market Size (2019-2030)
10.2 Middle East & Africa Molecular Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Molecular Testing Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Molecular Testing Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Molecular Testing Service Introduction
11.1.4 Merck Revenue in Molecular Testing Service Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Molecular Testing Service Introduction
11.2.4 Roche Revenue in Molecular Testing Service Business (2019-2024)
11.2.5 Roche Recent Development
11.3 ACM Global Laboratories
11.3.1 ACM Global Laboratories Company Detail
11.3.2 ACM Global Laboratories Business Overview
11.3.3 ACM Global Laboratories Molecular Testing Service Introduction
11.3.4 ACM Global Laboratories Revenue in Molecular Testing Service Business (2019-2024)
11.3.5 ACM Global Laboratories Recent Development
11.4 Molecular Testing Labs
11.4.1 Molecular Testing Labs Company Detail
11.4.2 Molecular Testing Labs Business Overview
11.4.3 Molecular Testing Labs Molecular Testing Service Introduction
11.4.4 Molecular Testing Labs Revenue in Molecular Testing Service Business (2019-2024)
11.4.5 Molecular Testing Labs Recent Development
11.5 Lab Test One
11.5.1 Lab Test One Company Detail
11.5.2 Lab Test One Business Overview
11.5.3 Lab Test One Molecular Testing Service Introduction
11.5.4 Lab Test One Revenue in Molecular Testing Service Business (2019-2024)
11.5.5 Lab Test One Recent Development
11.6 Hong Kong Molecular Pathology Diagnostic Centre (HKMPDC)
11.6.1 Hong Kong Molecular Pathology Diagnostic Centre (HKMPDC) Company Detail
11.6.2 Hong Kong Molecular Pathology Diagnostic Centre (HKMPDC) Business Overview
11.6.3 Hong Kong Molecular Pathology Diagnostic Centre (HKMPDC) Molecular Testing Service Introduction
11.6.4 Hong Kong Molecular Pathology Diagnostic Centre (HKMPDC) Revenue in Molecular Testing Service Business (2019-2024)
11.6.5 Hong Kong Molecular Pathology Diagnostic Centre (HKMPDC) Recent Development
11.7 Promega
11.7.1 Promega Company Detail
11.7.2 Promega Business Overview
11.7.3 Promega Molecular Testing Service Introduction
11.7.4 Promega Revenue in Molecular Testing Service Business (2019-2024)
11.7.5 Promega Recent Development
11.8 Quest Diagnostics Test Directory
11.8.1 Quest Diagnostics Test Directory Company Detail
11.8.2 Quest Diagnostics Test Directory Business Overview
11.8.3 Quest Diagnostics Test Directory Molecular Testing Service Introduction
11.8.4 Quest Diagnostics Test Directory Revenue in Molecular Testing Service Business (2019-2024)
11.8.5 Quest Diagnostics Test Directory Recent Development
11.9 The Doctors Laboratory
11.9.1 The Doctors Laboratory Company Detail
11.9.2 The Doctors Laboratory Business Overview
11.9.3 The Doctors Laboratory Molecular Testing Service Introduction
11.9.4 The Doctors Laboratory Revenue in Molecular Testing Service Business (2019-2024)
11.9.5 The Doctors Laboratory Recent Development
11.10 Mayo Clinic Laboratories
11.10.1 Mayo Clinic Laboratories Company Detail
11.10.2 Mayo Clinic Laboratories Business Overview
11.10.3 Mayo Clinic Laboratories Molecular Testing Service Introduction
11.10.4 Mayo Clinic Laboratories Revenue in Molecular Testing Service Business (2019-2024)
11.10.5 Mayo Clinic Laboratories Recent Development
11.11 Athena Diagnostics
11.11.1 Athena Diagnostics Company Detail
11.11.2 Athena Diagnostics Business Overview
11.11.3 Athena Diagnostics Molecular Testing Service Introduction
11.11.4 Athena Diagnostics Revenue in Molecular Testing Service Business (2019-2024)
11.11.5 Athena Diagnostics Recent Development
11.12 Rosalind Franklin University
11.12.1 Rosalind Franklin University Company Detail
11.12.2 Rosalind Franklin University Business Overview
11.12.3 Rosalind Franklin University Molecular Testing Service Introduction
11.12.4 Rosalind Franklin University Revenue in Molecular Testing Service Business (2019-2024)
11.12.5 Rosalind Franklin University Recent Development
11.13 Centre for Health Protection
11.13.1 Centre for Health Protection Company Detail
11.13.2 Centre for Health Protection Business Overview
11.13.3 Centre for Health Protection Molecular Testing Service Introduction
11.13.4 Centre for Health Protection Revenue in Molecular Testing Service Business (2019-2024)
11.13.5 Centre for Health Protection Recent Development
11.14 Queen Mary Hospital
11.14.1 Queen Mary Hospital Company Detail
11.14.2 Queen Mary Hospital Business Overview
11.14.3 Queen Mary Hospital Molecular Testing Service Introduction
11.14.4 Queen Mary Hospital Revenue in Molecular Testing Service Business (2019-2024)
11.14.5 Queen Mary Hospital Recent Development
11.15 Pharmigene
11.15.1 Pharmigene Company Detail
11.15.2 Pharmigene Business Overview
11.15.3 Pharmigene Molecular Testing Service Introduction
11.15.4 Pharmigene Revenue in Molecular Testing Service Business (2019-2024)
11.15.5 Pharmigene Recent Development
11.16 Dr Lal PathLabs
11.16.1 Dr Lal PathLabs Company Detail
11.16.2 Dr Lal PathLabs Business Overview
11.16.3 Dr Lal PathLabs Molecular Testing Service Introduction
11.16.4 Dr Lal PathLabs Revenue in Molecular Testing Service Business (2019-2024)
11.16.5 Dr Lal PathLabs Recent Development
11.17 Molecular Diagnostic Services
11.17.1 Molecular Diagnostic Services Company Detail
11.17.2 Molecular Diagnostic Services Business Overview
11.17.3 Molecular Diagnostic Services Molecular Testing Service Introduction
11.17.4 Molecular Diagnostic Services Revenue in Molecular Testing Service Business (2019-2024)
11.17.5 Molecular Diagnostic Services Recent Development
11.18 National Jewish Health
11.18.1 National Jewish Health Company Detail
11.18.2 National Jewish Health Business Overview
11.18.3 National Jewish Health Molecular Testing Service Introduction
11.18.4 National Jewish Health Revenue in Molecular Testing Service Business (2019-2024)
11.18.5 National Jewish Health Recent Development
11.19 UCLA Health
11.19.1 UCLA Health Company Detail
11.19.2 UCLA Health Business Overview
11.19.3 UCLA Health Molecular Testing Service Introduction
11.19.4 UCLA Health Revenue in Molecular Testing Service Business (2019-2024)
11.19.5 UCLA Health Recent Development
11.20 Cytiva
11.20.1 Cytiva Company Detail
11.20.2 Cytiva Business Overview
11.20.3 Cytiva Molecular Testing Service Introduction
11.20.4 Cytiva Revenue in Molecular Testing Service Business (2019-2024)
11.20.5 Cytiva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Merck
Roche
ACM Global Laboratories
Molecular Testing Labs
Lab Test One
Hong Kong Molecular Pathology Diagnostic Centre (HKMPDC)
Promega
Quest Diagnostics Test Directory
The Doctors Laboratory
Mayo Clinic Laboratories
Athena Diagnostics
Rosalind Franklin University
Centre for Health Protection
Queen Mary Hospital
Pharmigene
Dr Lal PathLabs
Molecular Diagnostic Services
National Jewish Health
UCLA Health
Cytiva
听
听
*If Applicable.
